Clinical pharmacology studies in patients with renal impairment: past experience and regulatory perspectives.
about
Pharmacokinetics and pharmacodynamics of liposomal mifamurtide in adult volunteers with mild or moderate renal impairment.Consequences of renal failure on non-renal clearance of drugs.Renal drug dosing recommendations: evaluation of product information for brands of the same drug.Emerging areas of research in the assessment of pharmacokinetics in patients with chronic kidney disease.The need for a national infrastructure to improve the rational use of therapeutics.Influence of kidney disease on drug disposition: An assessment of industry studies submitted to the FDA for new chemical entities 1999-2010.Update and trends on pharmacokinetic studies in patients with impaired renal function: practical insight into application of the FDA and EMA guidelines.Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches.Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011-2017: Lessons Learned for Anticancer Drug Development.
P2860
Q33887982-2B313E67-A699-47BD-A580-FD2084F87009Q38214827-99C9B302-3D6C-4E39-B362-A5606DCE4E65Q38221643-9B8EBB55-374C-4711-8BAE-144093F4BC5BQ38287050-86AD8311-E97A-420E-91E8-71EF133653B1Q38468151-3B82AB89-22A5-4A14-895E-AEABDCEE3EF8Q38560098-E52C651A-0092-468A-B1E6-DE8ACE4DDEB2Q39044774-AD481F83-75EF-4660-8668-FB9ED2B5891EQ42961049-1A8326AE-F2DD-4164-B956-761CF9168DF6Q52740762-8CBCAA96-9F30-4E77-897C-705583AC6F83
P2860
Clinical pharmacology studies in patients with renal impairment: past experience and regulatory perspectives.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Clinical pharmacology studies ...... e and regulatory perspectives.
@ast
Clinical pharmacology studies ...... e and regulatory perspectives.
@en
type
label
Clinical pharmacology studies ...... e and regulatory perspectives.
@ast
Clinical pharmacology studies ...... e and regulatory perspectives.
@en
prefLabel
Clinical pharmacology studies ...... e and regulatory perspectives.
@ast
Clinical pharmacology studies ...... e and regulatory perspectives.
@en
P2093
P1476
Clinical pharmacology studies ...... e and regulatory perspectives.
@en
P2093
P356
10.1177/00912700022008658
P577
2000-01-01T00:00:00Z